Copertina

Pharmacogenomics

This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision s...

Descrizione completa

Salvato in:
Natura: Online
Lingua:inglese
Pubblicazione: MDPI - Multidisciplinary Digital Publishing Institute 2022
Soggetti:
pharmacogenomics
return of results
genetic counseling
qualitative
pharmacogenetics
implementation
pharmacogenetics service
screening
pre-emptive
personalized medicine
precision medicine
community pharmacy
pharmacogenomic testing
genetic privacy
pharmaco-economics
polymorphisms
pharmacogenes
pharmacogenomic
machine learning
adaptation
human evolution
US Food and Drug Administration
clinical actionability
clinical translation
chronic kidney disease
CYP3A5
polymorphism
progression
pharmacogenomics (PGx)
pediatrics
best practice alerts (BPAs)
electronic health records (EHR)
genomic indicators
clinical decision support (CDS)
phenotype
genotype
polypharmacy
chronic disease
medication management
electronic medical record
artificial intelligence
n/a
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Accesso online:ONIX_20220506_9783036528359_133
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Riassunto:This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.

Documenti analoghi